A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview

RA Marrie, J Cohen, O Stuve… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS).
Objective: The objective of this review is to estimate the incidence and prevalence of …

Grey matter pathology in multiple sclerosis

JJG Geurts, F Barkhof - The Lancet Neurology, 2008 - thelancet.com
Multiple sclerosis (MS) has been classically regarded as a white matter disease. However,
recent histopathological studies have convincingly shown that grey matter regions are also …

Acute symptomatic seizures: an educational, evidence-based review

M Mauritz, LJ Hirsch, P Camfield, RFM Chin… - Epileptic …, 2022 - stm.cairn.info
Acute symptomatic seizures: an educational, evidence-based review | Cairn.info Cairn.info,
Matières à réflexion Cairn.info, Matières à réflexion Aucune suggestion trouvée Compte personnel …

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology

JJG Geurts, L Bö, PJW Pouwels… - American Journal …, 2005 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Cortical lesions constitute a substantial part of the total
lesion load in multiple sclerosis (MS) brain. They have been related to neuropsychological …

[HTML][HTML] Meningeal and cortical grey matter pathology in multiple sclerosis

BF Gh Popescu, CF Lucchinetti - BMC neurology, 2012 - Springer
Although historically considered a disease primarily affecting the white matter of the central
nervous system, recent pathological and imaging studies have established that cortical …

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

RA Marrie, N Reider, J Cohen… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background: Several studies have suggested that comorbid neurologic disorders are more
common than expected in multiple sclerosis (MS). Objective: To estimate the incidence and …

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice

JCC de Sa, L Airas, E Bartholome… - Therapeutic …, 2011 - journals.sagepub.com
As more investigations into factors affecting the quality of life of patients with multiple
sclerosis (MS) are undertaken, it is becoming increasingly apparent that certain …

A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic

LJ Edwards, CS Constantinescu - Multiple Sclerosis Journal, 2004 - journals.sagepub.com
The cause of multiple sclerosis (MS) remains unknown. It is largely regarded as being an
inflammatory autoimmune disease and has been reported in association with other …

3D MPRAGE improves classification of cortical lesions in multiple sclerosis

F Nelson, A Poonawalla, P Hou… - Multiple Sclerosis …, 2008 - journals.sagepub.com
Background Gray matter lesions are known to be common in multiple sclerosis (MS) and are
suspected to play an important role in disease progression and clinical disability. A …

Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody …

EC Li, Y Zheng, MT Cai, QL Lai, GL Fang, BQ Du… - …, 2022 - Wiley Online Library
Seizure is one of the manifestations of central nervous system inflammatory demyelinating
diseases, which mainly include multiple sclerosis (MS), aquaporin 4 antibody‐positive …